In CVID patients, six out of nine (66%) selected CpGs (AICDA, BCL6, FOXO, AKT1, NFKB2, and STAT3) showed significant hypermethylation in switched memory B cells in comparison to healthy donors. This evidence concerns the gene BCL6 and common variable immunodeficiency.